These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 6451131

  • 1. General considerations by a clinical bacteriologist regarding antibiotic therapy in acne.
    Holm SE, Burman LG.
    Acta Derm Venereol Suppl (Stockh); 1980; Suppl 89():83-5. PubMed ID: 6451131
    [No Abstract] [Full Text] [Related]

  • 2. Acne: emphasis on adolescent acne and the role of antibiotics.
    Rich M.
    Aust Fam Physician; 1980 Nov; 9(11):768-74. PubMed ID: 6452113
    [No Abstract] [Full Text] [Related]

  • 3. Ad Hoc Committee report: systemic antibiotics for treatment of acne vulgaris: efficacy and safety.
    Arch Dermatol; 1975 Dec; 111(12):1630-6. PubMed ID: 128326
    [No Abstract] [Full Text] [Related]

  • 4. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.
    Schafer F, Fich F, Lam M, Gárate C, Wozniak A, Garcia P.
    Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195
    [Abstract] [Full Text] [Related]

  • 5. Resistance of propionibacteria to antibiotics used in the treatment of acne.
    Brown JM, Poston SM.
    J Med Microbiol; 1983 Aug; 16(3):271-80. PubMed ID: 6224016
    [Abstract] [Full Text] [Related]

  • 6. [Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy].
    Abeck D.
    MMW Fortschr Med; 2003 Dec 18; 145(51-52):29. PubMed ID: 14974325
    [No Abstract] [Full Text] [Related]

  • 7. Topical antibiotics and topical antimicrobial agents in acne therapy.
    Leyden JJ, McGinley K, Mills OH, Kligman AM.
    Acta Derm Venereol Suppl (Stockh); 1980 Dec 18; Suppl 89():75-82. PubMed ID: 6451130
    [No Abstract] [Full Text] [Related]

  • 8. [In vitro resistance of Propionibacterium acnes and Staphylococcus epidermidis to antibiotics: should our antibiotic prescription practices for the treatment of acne be changed?].
    Bourgault-Villada I.
    Ann Dermatol Venereol; 1998 Dec 18; 125(12):879-80. PubMed ID: 9922858
    [No Abstract] [Full Text] [Related]

  • 9. [General antibiotic therapy in acne].
    Dréno B.
    Rev Prat; 2002 Apr 15; 52(8):841-3. PubMed ID: 12053791
    [Abstract] [Full Text] [Related]

  • 10. Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones.
    Resh W, Stoughton RB.
    Arch Dermatol; 1976 Feb 15; 112(2):182-4. PubMed ID: 134675
    [Abstract] [Full Text] [Related]

  • 11. Nasal antibiotic-resistant Propionibacterium acnes carriage in acne vulgaris patients in Turkey.
    Ergin C, Ergin S, Kaleli I, Kaçar N, Sengül M, Erdoğan BS.
    J Dermatol; 2006 Dec 15; 33(12):899-901. PubMed ID: 17169100
    [No Abstract] [Full Text] [Related]

  • 12. In vitro antimicrobial susceptibility of Propionibacterium acnes isolated from acne patients in northern Mexico.
    González R, Welsh O, Ocampo J, Hinojosa-Robles RM, Vera-Cabrera L, Delaney ML, Gómez M.
    Int J Dermatol; 2010 Sep 15; 49(9):1003-7. PubMed ID: 20931669
    [Abstract] [Full Text] [Related]

  • 13. In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study.
    Abdel Fattah NS, Darwish YW.
    J Eur Acad Dermatol Venereol; 2013 Dec 15; 27(12):1546-51. PubMed ID: 23279041
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris.
    Ishida N, Nakaminami H, Noguchi N, Kurokawa I, Nishijima S, Sasatsu M.
    Microbiol Immunol; 2008 Dec 15; 52(12):621-4. PubMed ID: 19120976
    [Abstract] [Full Text] [Related]

  • 15. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B, Foulc P, Reynaud A, Moyse D, Habert H, Richet H.
    Eur J Dermatol; 2005 Dec 15; 15(3):152-5. PubMed ID: 15908296
    [Abstract] [Full Text] [Related]

  • 16. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
    Kurokawa I, Nishijima S, Kawabata S.
    Eur J Dermatol; 1999 Dec 15; 9(1):25-8. PubMed ID: 9920982
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne.
    Gübelin W, Martínez MA, Molina MT, Zapata S, Valenzuela ME.
    Rev Latinoam Microbiol; 2006 Dec 15; 48(1):14-6. PubMed ID: 17357569
    [Abstract] [Full Text] [Related]

  • 18. The treatment of acne. Part III: antibacterials.
    Kligman AM.
    Cutis; 1995 Dec 15; 56(6):315-6. PubMed ID: 8654122
    [No Abstract] [Full Text] [Related]

  • 19. Antimicrobial susceptibility of Propionibacterium acnes isolates from acne patients in Colombia.
    Mendoza N, Hernandez PO, Tyring SK, Haitz KA, Motta A.
    Int J Dermatol; 2013 Jun 15; 52(6):688-92. PubMed ID: 23451873
    [Abstract] [Full Text] [Related]

  • 20. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance.
    Leyden JJ, Del Rosso JQ, Webster GF.
    Cutis; 2007 Jun 15; 79(6 Suppl):9-25. PubMed ID: 17649854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.